Found: 42
Select item for more details and to access through your institution.
Adjustment of young women with breast cancer after chemotherapy: A mediation model of emotional competence via emotional distress.
- Published in:
- Psycho-Oncology, 2022, v. 31, n. 5, p. 848, doi. 10.1002/pon.5876
- By:
- Publication type:
- Article
The von Willebrand factor stamps plasmatic extracellular vesicles from glioblastoma patients.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-02254-7
- By:
- Publication type:
- Article
Standard 6-week chemoradiation for elderly patients with newly diagnosed glioblastoma.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-01537-3
- By:
- Publication type:
- Article
Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 1, p. 191, doi. 10.1007/s10549-021-06382-6
- By:
- Publication type:
- Article
Patient-centered simulations to assess the usefulness of the 70-gene signature for adjuvant chemotherapy administration in early-stage breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 174, n. 2, p. 537, doi. 10.1007/s10549-018-05107-6
- By:
- Publication type:
- Article
Modulation of DNA Methylation/Demethylation Reactions Induced by Nutraceuticals and Pollutants of Exposome Can Promote a C > T Mutation in the Breast Cancer Predisposing Gene PALB2.
- Published in:
- Epigenomes, 2022, v. 6, n. 4, p. 32, doi. 10.3390/epigenomes6040032
- By:
- Publication type:
- Article
Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0304556
- By:
- Publication type:
- Article
Paracaspase MALT1 regulates glioma cell survival by controlling endo‐lysosome homeostasis.
- Published in:
- EMBO Journal, 2020, v. 39, n. 1, p. N.PAG, doi. 10.15252/embj.2019102030
- By:
- Publication type:
- Article
An Update on the Clinical Use of CDK4/6 Inhibitors in Breast Cancer.
- Published in:
- Drugs, 2018, v. 78, n. 13, p. 1353, doi. 10.1007/s40265-018-0972-9
- By:
- Publication type:
- Article
Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME database.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221077082
- By:
- Publication type:
- Article
Opportunities and Obstacles to the Development of Health Data Warehouses in Hospitals in France: The Recent Experience of Comprehensive Cancer Centers.
- Published in:
- International Journal of Environmental Research & Public Health, 2023, v. 20, n. 2, p. 1645, doi. 10.3390/ijerph20021645
- By:
- Publication type:
- Article
Optimizing the Retrieval of the Vital Status of Cancer Patients for Health Data Warehouses by Using Open Government Data in France.
- Published in:
- International Journal of Environmental Research & Public Health, 2022, v. 19, n. 7, p. 4272, doi. 10.3390/ijerph19074272
- By:
- Publication type:
- Article
Comparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 9, p. e2231170, doi. 10.1001/jamanetworkopen.2022.31170
- By:
- Publication type:
- Article
Long-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1191, doi. 10.3390/cancers15041191
- By:
- Publication type:
- Article
Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade IDH -Mutant Gliomas: A French POLA Network Study.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5509, doi. 10.3390/cancers14225509
- By:
- Publication type:
- Article
Long-Term Use of Proton Pump Inhibitors in Cancer Patients: An Opinion Paper.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1156, doi. 10.3390/cancers14051156
- By:
- Publication type:
- Article
Survival Outcomes after Hyperthermic Intraperitoneal Chemotherapy for a First Ovarian Cancer Relapse: A Systematic Evidence-Based Review.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 172, doi. 10.3390/cancers14010172
- By:
- Publication type:
- Article
Development of a Prognostic Tool to Guide the Decision to Extend Adjuvant Aromatase Inhibitors for up to Ten Years in Postmenopausal Early Breast Cancer Patients.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3725, doi. 10.3390/cancers12123725
- By:
- Publication type:
- Article
bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses.
- Published in:
- Database: The Journal of Biological Databases & Curation, 2013, v. 2013, p. 1, doi. 10.1093/database/bas060
- By:
- Publication type:
- Article
Ribosome biogenesis‐based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 1, p. 27, doi. 10.1002/1878-0261.13340
- By:
- Publication type:
- Article
Efficacy of palbociclib plus fulvestrant after everolimus in hormone receptor-positive metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 168, n. 2, p. 559, doi. 10.1007/s10549-017-4623-8
- By:
- Publication type:
- Article
Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 157, n. 2, p. 307, doi. 10.1007/s10549-016-3828-6
- By:
- Publication type:
- Article
Association of Endocrine Therapy for HR+/ERBB2+ Metastatic Breast Cancer With Survival Outcomes.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 12, p. e2247154, doi. 10.1001/jamanetworkopen.2022.47154
- By:
- Publication type:
- Article
Glyphosate Primes Mammary Cells for Tumorigenesis by Reprogramming the Epigenome in a TET3-Dependent Manner.
- Published in:
- Frontiers in Genetics, 2019, p. 1, doi. 10.3389/fgene.2019.00885
- By:
- Publication type:
- Article
The EPICURE study: a pilot prospective cohort study of heterogeneous and massive data integration in metastatic breast cancer patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Bevacizumab Efficacy Is Influenced by Primary Tumor Resection in First-Line Treatment of Metastatic Colorectal Cancer in a Retrospective Multicenter Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Mammary carcinoma: Comparative oncology between small animals and humans—New therapeutic tools.
- Published in:
- Reproduction in Domestic Animals, 2023, v. 58, p. 102, doi. 10.1111/rda.14408
- By:
- Publication type:
- Article
Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 2, p. 439, doi. 10.1002/ijc.32606
- By:
- Publication type:
- Article
Anti-PD1 therapy induces lymphocyte-derived exosomal miRNA-4315 release inhibiting Bim-mediated apoptosis of tumor cells.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 12, p. 1, doi. 10.1038/s41419-020-03224-z
- By:
- Publication type:
- Article
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prevalence of Proton Pump Inhibitor Use Among Patients With Cancer.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 6, p. e2113739, doi. 10.1001/jamanetworkopen.2021.13739
- By:
- Publication type:
- Article
Endocrine therapy in advanced high-grade ovarian cancer: real-life data from a multicenter study and a review of the literature.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. e910, doi. 10.1093/oncolo/oyae093
- By:
- Publication type:
- Article
Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study.
- Published in:
- Oncologist, 2022, v. 27, n. 5, p. 414, doi. 10.1093/oncolo/oyac023
- By:
- Publication type:
- Article
Emotional processes in partners' quality of life at various stages of breast cancer pathway: a longitudinal study.
- Published in:
- Quality of Life Research, 2023, v. 32, n. 4, p. 1085, doi. 10.1007/s11136-022-03298-6
- By:
- Publication type:
- Article
Ovarian Real-World International Consortium (ORWIC): A multicentre, real-world analysis of epithelial ovarian cancer treatment and outcomes.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1114435
- By:
- Publication type:
- Article
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 9, p. 1670, doi. 10.1093/neuonc/noae053
- By:
- Publication type:
- Article
Corrigendum to: Experience of patients with metastatic breast cancer in France: results of the 2021 RÉALITÉS survey and comparison with 2015 results.
- Published in:
- Oncologie (De Gruyter), 2023, v. 25, n. 5, p. 589, doi. 10.1515/oncologie-2023-0357
- By:
- Publication type:
- Article
Experience of patients with metastatic breast cancer in France: results of the 2021 RÉALITÉS survey and comparison with 2015 results.
- Published in:
- Oncologie (De Gruyter), 2023, v. 25, n. 3, p. 211, doi. 10.1515/oncologie-2022-1018
- By:
- Publication type:
- Article
Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40569-9
- By:
- Publication type:
- Article
Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40569-9
- By:
- Publication type:
- Article
Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 5, p. 825, doi. 10.1007/s12282-024-01597-z
- By:
- Publication type:
- Article
CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients.
- Published in:
- Breast Cancer (13406868), 2023, v. 30, n. 2, p. 315, doi. 10.1007/s12282-022-01426-1
- By:
- Publication type:
- Article